R. Floyd
Keine laufenden Positionen mehr
Profil
R.
Michael Floyd was the founder of Elion Oncology, Inc. which was founded in 2016, where he held the titles of President, Chief Executive Officer & Director.
Mr. Floyd is also the founder of BioAim LLC, Exbaq LLC.
He previously worked as the Chief Executive Officer-North America at Evolva Holding SA. He also worked as the Chief Operating Officer at Processa Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Floyd obtained his undergraduate degree from Georgetown University.
Ehemalige bekannte Positionen von R. Floyd
Unternehmen | Position | Ende |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Chief Operating Officer | 31.08.2023 |
BioAim LLC | Founder | - |
Exbaq LLC | Founder | - |
EVOLVA HOLDING SA | Corporate Officer/Principal | - |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD. | Founder | - |
Ausbildung von R. Floyd
Georgetown University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EVOLVA HOLDING SA | Consumer Non-Durables |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD. | Health Technology |
BioAim LLC | |
Exbaq LLC |